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Volume 60, Number 6 Cull et al 1541wound therapy or hyperbaric oxygen treatments. Decisions
to treat the wounds with those modalities were usually
determined by the wound characteristics and the patient’s
insurance status. Such differences among study patients like-
wise might have inﬂuenced our limb salvage and wound
healing rates. When future studies using the WIfI classiﬁca-
tion system to evaluate treatment modalities for CLI are
developed, a standardized wound management protocol
should be adopted to mitigate the effects of this potential
confounding variable that could inﬂuence outcome.
The WIfI classiﬁcation system recommends noting
whether neuropathy is present. We did not evaluate patients
for the presence or absence of neuropathy. Although origi-
nally included as a factor in our study, it was soon aban-
doned due to inconsistency in grading among physicians.
Finally, the inclusion of multiple limbs and wounds
from a single patient resulted in a larger analytic sample
and could constitute a lack of independence of observa-
tions. Therefore, we conducted a similar set of analyses
including only a single wound per patient (n ¼ 139). Esti-
mated odds ratios from both analyses were similar; howev-
er, the precision of these estimates was generally improved
when including multiple wounds and limbs.
CONCLUSIONS
Our study provides early clinical validation of the WIfI
classiﬁcation system. The 1-year limb salvage rate for pa-
tients in our series correlated not only with the WIfI clinical
stage but also with the outcome predicted by the panel of
experts who established the WIfI. Our study also showed
that the WIfI clinical stage correlated with wound healing.
Multicenter studies comprising more patients are justiﬁed
to fully validate the WIfI classiﬁcation system. In the
future, once additional components such as a patient risk
index are added to the WIfI classiﬁcation system, the sys-
tem holds promise as a tool for comparing treatment mo-
dalities in clinical trials and as a clinical decision-making
tool for guiding therapy in patients with CLI.
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Submitted Jun 9, 2014; accepted Aug 26, 2014.DISCUSSIONDrRichardNeville (Washington, D.C.). DrCull, I thoroughly
appreciate this important work on wound analysis from your
group. I have two questions: First, what methodology did you
use to actually measure the wound? Was it largest transverse diam-
eter? Do you have a reproducible way to measure the wounds? Sec-
ondly, with this type of study it is interesting to note the wound
care the patients received. Did the study involve protocol-driven
wound care for each patient to assure a standard approach? Forexample, did some patients get free ﬂaps, some rotational ﬂaps,
or some people just got wet-to-dry dressings? How did you
account for the different kinds of wound care?
Dr David L. Cull. We calculated the area by multiplying the
length and width of the wound. Your second question regarding
the wound care each patient received is important. Wound care
was not standardized in this study. We made the assumption that
all patients received optimal wound care; however, this assumption
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care treatment while others were not. Some patients received hyper-
baric oxygen therapy or negative pressure wound therapy, while
others did not. This is a limitation of our study. Sixty-two percent
of patients received wound care in a wound care clinic. When we
ran the bivariate analysis, we were surprised to learn that the patients
who received treatment in the wound care clinic did poorer than
those who did not. But on further analysis, we found that the
wound care clinic patients tended to have larger wounds.
Dr Anil Hingorani (Brooklyn, NY). Just one brief question
about the Wound characteristic, Ischemia, and foot Infection
(WIfI) system. Were you able to identify a subset of patients
who did not do welld90% of them did not heal, 90% of them
ended up with limb loss? In your data set you said your stage 4 pa-
tients were 50/50.
Dr Cull. Although our study showed that only 40% of stage 4
patients ultimately ended up with an amputation at 1 year, our
study methodology most certainly underestimated limb amputa-
tion for that stage. Our study only included patients who under-
went a revascularization procedure. Because most patients
presenting with stage 4 disease were not offered a revascularization
procedure but rather underwent primary limb amputation, they
were not included. Had they been included, the outcome for the
stage 4 category would have been much worse.
Dr Frank Logerfo (Boston, Mass). This is a terriﬁc effort on
the part of the Society to deﬁne what patients we should operate
on and to some extent what operation we should do. People
with diabetes and a foot ulcer, who have signiﬁcant ischemia,
that means you cannot feel a pulse in the foot, should just go right
to revascularization. With diabetes, the neuroinﬂammatory
response is lost and we cannot measure the total baseline biological
impairment or the susceptibility of the diabetic foot to ischemia.
Therefore the term “critical ischemia” becomes undeﬁnable. If
someone has a foot ulcer and you cannot feel a pulse, whatever
is going on in that foot, it cannot remain healed in daily life.
The measurable circulation may be identical in two people but
“critical” in one but not the other, depending on the baseline bio-
logical impairment. Some people with diabetes can have perfect
circulation and still have foot ulcers because they have no neuroin-
ﬂammatory response and no somatic neurologic sensation.In your data, the patients I would look at most carefully are
those in the lower classiﬁcations that wound up with amputation.
Why did that happen and have you looked in detail at each of
them?
Dr Cull. Since there were so few limb amputations in the
stage 1 and 2 categories, we were unable to go into any more
detail, beyond the analysis we did, to further reﬁne the WIfI clas-
siﬁcation. The variability of patients presenting with limb threat
makes such analysis difﬁcult. Full validation of the WIfI classiﬁca-
tion system will take many more patients than were generated by
our study. Your statement that all diabetic patients with a foot ul-
cer who do not have a pulse should undergo revascularization is a
principle I have followed for the ﬁrst 15 years of my practice. In
2007, we decided to challenge that principle with the hypothesis
that a small wound that is not infected requires less perfusion to
heal than a large wound or an infected wound. That hypothesis
is the foundation of the WIfI classiﬁcation system. Our study seems
to validate that hypothesis.
Dr Pierre Karam (Montreal, Quebec, Canada). I have two
questions. The ﬁrst is how practical is it to apply the WIfI system
in our practice? And the second question, in the subgroup of pa-
tients with end-stage renal disease, do you have any data on how
they correlate with the WIfI staging?
Dr Cull. The bivariate analysis did not show that patients
with end-stage renal disease fared any worse than those patients
without renal disease. This could be due to selection bias.
Again, our study only included patients who underwent a
revascularization procedure. It is possible that patients with
end-stage renal disease were only offered a revascularization
procedure in selective cases where a favorable outcome was
more certain.
Regarding your question on how practical it is to obtain the
information in order to obtain a WIfI clinical stage, we found
the process of grading the wound, the degree of ischemia, and
the extent of infection both quick and easy. On paper, the staging
looks more arduous than it is in practice. In the future, the Society
for Vascular Surgery Lower Extremity Guidelines Committee
hopes to add anatomic information and a patient comorbidity in-
dex in order to create a tool to guide therapy. That will add a layer
of complexity to the model.
